NCT03889210

Brief Summary

The study aims to investigate changes in blood glucose metabolism after administration of a ketone ester drink.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 26, 2019

Completed
6 days until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2019

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2019

Completed
Last Updated

November 6, 2019

Status Verified

November 1, 2019

Enrollment Period

5 months

First QC Date

March 18, 2019

Last Update Submit

November 4, 2019

Conditions

Keywords

KetonesPrediabetes

Outcome Measures

Primary Outcomes (1)

  • Rate of change in plasma glucose concentration

    Changes in plasma glucose concentration before and after administration of the intervention/placebo

    Baseline, 30, 60, 90, 120, and 150 minutes

Secondary Outcomes (9)

  • Rate of change in plasma insulin and C-peptide concentrations

    Baseline, 30, 60, 90, 120, and 150 minutes

  • Rate of change in plasma concentration of gut and pancreatic hormones

    Baseline, 30, 60, 90, 120, and 150 minutes

  • Rate of change in lipid profile and digestive enzymes

    Baseline, 30, 60, 90, 120, and 150 minutes

  • Rate of change in plasma concentration of pro-inflammatory cytokines

    Baseline, 30, 60, 90, 120, and 150 minutes

  • Rate of change in plasma concentration of markers of iron metabolism

    Baseline, 30, 60, 90, 120, and 150 minutes

  • +4 more secondary outcomes

Study Arms (2)

HVMN ketone drink

ACTIVE COMPARATOR

HVMN ketone drink will be given in a total volume of 100 ml.

Other: HVMN Ketone

Placebo

PLACEBO COMPARATOR

Placebo will be given in a total volume of 100 ml.

Other: Placebo

Interventions

Water-based, flavoured sport beverage

HVMN ketone drink
PlaceboOTHER

Water, stevia, malic acid, and thickening agent

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals over 18 years
  • Individuals diagnosed with prediabetes; defined based on the American Diabetes Association guidelines
  • History of at least one episode of acute pancreatitis
  • Written informed consent

You may not qualify if:

  • Individuals who are on a ketogenic diet or consuming nutritional ketone supplements
  • History of cancer or chronic pancreatitis
  • History of bariatric or gastrointestinal surgery
  • Pregnant or breastfeeding women
  • Individuals involved in intensive endurance training or competitive athletics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Auckland; Auckland City Hospital

Auckland, New Zealand

Location

Related Publications (6)

  • Charles S, Liu Y, Bharmal SH, Kimita W, Petrov MS. Effect of Acute Nutritional Ketosis on Circulating Levels of Growth Differentiation Factor 15: Findings from a Cross-Over Randomised Controlled Trial. Biomolecules. 2024 Jun 6;14(6):665. doi: 10.3390/biom14060665.

  • Charles S, Liu Y, Kimita W, Ko J, Bharmal SH, Petrov MS. Effect of D-beta-hydroxybutyrate-(R)-1,3 butanediol on plasma levels of asprosin and leptin: results from a randomised controlled trial. Food Funct. 2023 Jan 23;14(2):759-768. doi: 10.1039/d2fo02405e.

  • Liu Y, Bharmal SH, Kimita W, Petrov MS. Effect of d-beta-Hydroxybutyrate-(R)-1,3 Butanediol on Appetite Regulation in People with Prediabetes. Mol Nutr Food Res. 2023 Feb;67(4):e2200615. doi: 10.1002/mnfr.202200615. Epub 2023 Jan 26.

  • Liu Y, Bharmal SH, Kimita W, Petrov MS. Effect of acute ketosis on lipid profile in prediabetes: findings from a cross-over randomized controlled trial. Cardiovasc Diabetol. 2022 Jul 23;21(1):138. doi: 10.1186/s12933-022-01571-z.

  • Bharmal SH, Alarcon Ramos GC, Ko J, Petrov MS. Abdominal fat distribution modulates the metabolic effects of exogenous ketones in individuals with new-onset prediabetes after acute pancreatitis: Results from a randomized placebo-controlled trial. Clin Nutr ESPEN. 2021 Jun;43:117-129. doi: 10.1016/j.clnesp.2021.03.013. Epub 2021 Mar 21.

  • Bharmal SH, Cho J, Alarcon Ramos GC, Ko J, Cameron-Smith D, Petrov MS. Acute Nutritional Ketosis and Its Implications for Plasma Glucose and Glucoregulatory Peptides in Adults with Prediabetes: A Crossover Placebo-Controlled Randomized Trial. J Nutr. 2021 Apr 8;151(4):921-929. doi: 10.1093/jn/nxaa417.

MeSH Terms

Conditions

Prediabetic StateKetosis

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAcidosisAcid-Base Imbalance

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 18, 2019

First Posted

March 26, 2019

Study Start

April 1, 2019

Primary Completion

August 16, 2019

Study Completion

August 30, 2019

Last Updated

November 6, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations